A new Lancet commentary sounds the alarm on merbecoviruses found in Chinese bats that can bind to human ACE2 receptors—the same entry point used by SARS-CoV-2. For professionals monitoring global health security, the implication is clear: the next coronavirus may already be circulating.
Chinese scientists have identified a critical genetic threat hiding in plain sight. A recent commentary published in The Lancet Microbe highlights a subgenus of betacoronaviruses known as merbecoviruses, isolated from Pipistrellus bats in China and elsewhere, that possess an alarming capability: they can bind to angiotensin-converting enzyme 2 (ACE2), the same cellular receptor that allowed SARS-CoV-2 to ignite a global pandemic.
Among the strains studied are HKU5-CoV-2, isolated in China, alongside variants from Hong Kong, the Netherlands, and Russia. This ability to dock onto ACE2 was first observed in African bat merbecoviruses such as NeoCoV and PDF-2180, but its presence across geographically dispersed bat populations signals a far wider and more entrenched evolutionary adaptation than previously appreciated. For China, where dense urban populations and live-animal markets create fertile ground for zoonotic spillover, the discovery carries profound implications for pandemic preparedness.
What makes this finding particularly unsettling is that merbecoviruses are genetically distinct from the sarbecovirus lineage that includes SARS-CoV-2. This means existing vaccines and therapeutics, designed specifically for the SARS-CoV-2 spike protein, may offer limited or no protection. The commentary calls for accelerated surveillance of bat reservoirs, especially in southern China, and for the development of broadly neutralizing coronavirus vaccines that can target multiple subgenera. For healthcare systems still recovering from the last pandemic, the message is sobering: nature is running its own R&D, and it is not pausing for humanity to catch up.
Why it matters:
This discovery underscores the urgency of proactive viral surveillance in China’s bat populations, as the next pandemic-capable pathogen may already be adapting to human receptors. For global health agencies and pharmaceutical developers, it reinforces the need for pan-coronavirus vaccine platforms that are not limited by existing strain-specific designs. Ignoring these signals could mean repeating the cycle of reaction rather than prevention.
ScientificChina — tracking what’s happening in Chinese science, technology, research, and industrial innovation in a way global professionals can actually use.
Follow ScientificChina for deeper insight into China’s evolving science, technology, and industrial landscape.
No products in the cart.